Skip to main content
. 2018 Jun 6;13:1091–1098. doi: 10.2147/CIA.S157048

Table 1.

Characteristics of the participants

Characteristics of the participants Tertile 1, n=257, 3–10 ng/L Tertile 2, n=231, 11–16 ng/L Tertile 3, n=234, ≥17 ng/L P-value
Baseline characteristics
 Age (years) 79.77±6.13 83.04±5.24 84.73±5.34 <0.001
 Male gender 140 (54.5) 152 (65.8) 181 (77.4) <0.001
 Body mass index (kg/m2) 23.39±3.30 23.62±3.30 23.80±3.29 0.376
 Heart rate (beats/min) 72.31±12.08 74.23±13.22 75.23±13.51 0.058
Comorbidities
 CAD 64 (24.9) 78 (33.8) 91 (38.9) 0.004
 Hypertension 194 (75.5) 182 (78.8) 203 (86.8) 0.006
 DM 77 (30) 97 (42) 99 (42.3) 0.005
 Cerebral infarction 145 (56.4) 136 (58.9) 154 (65.8) 0.092
 COPD 37 (14.4) 42 (18.2) 59 (25.2) 0.009
 CKD 43 (16.7) 49 (21.2) 84 (35.9) <0.001
 AF 30 (11.7) 45 (19.5) 31 (13.2) 0.039
Number of comorbidities
 ≤1 78 (30.4) 46 (19.9) 31 (13.2) <0.001
 2–3 137 (53.3) 119 (51.5) 112 (47.9) 0.258
 ≥4 42 (16.3) 66 (28.6) 91 (38.9) <0.001
Biochemistry
 NT-proBNP (pg/mL) 171 (80.06, 402.90) 297 (147.10, 606.50) 562.1 (225.40, 1,174.00) <0.001
 eGFR (mL/min·1.73 m2) 78.73±22.69 76.48±23.59 67.86±27.54 <0.001
 Hb (g/L) 131.35±15.53 128.84±19.39 123.44±21.92 <0.001
 FBG (mmol/L) 5.41±1.30 5.66±1.96 5.83±2.24 0.041
Echocardiography
 LVEF (%) 59.97±3.40 59.33±4.00 57.89±3.34 <0.001
 LVMI (g/m2) 117.90±31.90 123.73±37.40 128.42±40.64 0.008

Notes: Data are presented as number (%) or mean±SD or median (interquartile range). P-value is for comparison by ANOVA or Kruskal–Wallis tests.

Abbreviations: CAD, coronary artery disease; DM, diabetes mellitus; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; AF, atrial fibrillation; NT-proBNP, amino-terminal pro-brain natriuretic peptide; eGFR, estimated glomerular filtration rate; Hb, hemoglobin; FBG, fasting blood glucose; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index.